Search Results - "Thomas, Gareth J"

Refine Results
  1. 1

    Pan-cancer deconvolution of tumour composition using DNA methylation by Chakravarthy, Ankur, Furness, Andrew, Joshi, Kroopa, Ghorani, Ehsan, Ford, Kirsty, Ward, Matthew J., King, Emma V., Lechner, Matt, Marafioti, Teresa, Quezada, Sergio A., Thomas, Gareth J., Feber, Andrew, Fenton, Tim R.

    Published in Nature communications (13-08-2018)
    “…The nature and extent of immune cell infiltration into solid tumours are key determinants of therapeutic response. Here, using a DNA methylation-based approach…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition by Elkington, Paul T, Bateman, Adrian C, Thomas, Gareth J, Ottensmeier, Christian H

    “…Antituberculosis treatment was initiated, which led to clinical improvement, normalization of liver function tests, and regression of the lung lesion. [...]the…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Characterising cancer-associated fibroblast heterogeneity in non-small cell lung cancer: a systematic review and meta-analysis by Irvine, Andrew F., Waise, Sara, Green, Edward W., Stuart, Beth, Thomas, Gareth J.

    Published in Scientific reports (12-02-2021)
    “…Cancer-associated fibroblasts (CAFs) are a key component of the tumour microenvironment with evidence suggesting they represent a heterogeneous population…”
    Get full text
    Journal Article
  7. 7

    Human tissue models in cancer research: looking beyond the mouse by Jackson, Samuel J, Thomas, Gareth J

    Published in Disease models & mechanisms (01-08-2017)
    “…Mouse models, including patient-derived xenograft mice, are widely used to address questions in cancer research. However, there are documented flaws in these…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Targeting Head and Neck Cancer by Vaccination by Wang, Chuan, Dickie, James, Sutavani, Ruhcha V, Pointer, Catherine, Thomas, Gareth J, Savelyeva, Natalia

    Published in Frontiers in immunology (23-04-2018)
    “…Head and neck cancer (HNC) is a heterogeneous group of squamous cell cancers that affect the oral cavity, pharynx, and larynx. Worldwide, it is the sixth most…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Cancer-Associated Fibroblasts in Oral Cancer: A Current Perspective on Function and Potential for Therapeutic Targeting by Bienkowska, Kamila J, Hanley, Christopher J, Thomas, Gareth J

    Published in Frontiers in oral health (01-07-2021)
    “…The role of the tumour microenvironement (TME) in cancer progression and resistance to therapies is now widely recognized. The most prominent non-immune cell…”
    Get full text
    Journal Article
  15. 15
  16. 16

    YAP drives cutaneous squamous cell carcinoma formation and progression by Vincent-Mistiaen, Zoé, Elbediwy, Ahmed, Vanyai, Hannah, Cotton, Jennifer, Stamp, Gordon, Nye, Emma, Spencer-Dene, Bradley, Thomas, Gareth J, Mao, Junhao, Thompson, Barry

    Published in eLife (20-09-2018)
    “…Squamous cell carcinoma (SCC) can progress to malignant metastatic cancer, including an aggressive subtype known as spindle cell carcinoma (spSCC). spSCC…”
    Get full text
    Journal Article
  17. 17

    The Nrf2 transcription factor contributes to resistance to cisplatin in bladder cancer by Hayden, Annette, Ph.D, Douglas, James, M.D, Sommerlad, Matthew, M.D, Andrews, Lawrence, Ph.D, Gould, Katherine, B.Sc, Hussain, Syed, M.D., Ph.D, Thomas, Gareth J., M.D., Ph.D, Packham, Graham, Ph.D, Crabb, Simon J., M.D., Ph.D

    Published in Urologic oncology (01-08-2014)
    “…Abstract Objectives Cisplatin is the key systemic chemotherapeutic agent used for bladder cancer, but chemoresistance is a major clinical problem. The…”
    Get full text
    Journal Article
  18. 18

    JAML immunotherapy targets recently activated tumor-infiltrating CD8+ T cells by Eschweiler, Simon, Wang, Alice, Ramírez-Suástegui, Ciro, von Witzleben, Adrian, Li, Yingcong, Chee, Serena J., Simon, Hayley, Mondal, Monalisa, Ellis, Matthew, Thomas, Gareth J., Chandra, Vivek, Ottensmeier, Christian H., Vijayanand, Pandurangan

    Published in Cell reports (Cambridge) (28-02-2023)
    “…Junctional adhesion molecule-like protein (JAML) serves as a co-stimulatory molecule in γδ T cells. While it has recently been described as a cancer…”
    Get full text
    Journal Article
  19. 19

    Treatment of actinic keratosis through inhibition of cyclooxygenase‐2: Potential mechanism of action of diclofenac sodium 3% in hyaluronic acid 2.5 by Thomas, Gareth J., Herranz, Pedro, Cruz, Susana Balta, Parodi, Aurora

    Published in Dermatologic therapy (01-05-2019)
    “…Cyclooxygenase‐2 (COX‐2) and its metabolic product prostaglandin E2 (PGE2) are induced in response to growth factors, inflammatory cytokines, tumor promoters,…”
    Get full text
    Journal Article
  20. 20